Sinopharm Tech Holdings Limited (HK:8156)
:8156
Want to see HK:8156 full AI Analyst Report?
Top Page
Sinopharm Tech Holdings Limited
(8156)
Select Model
Select Model
Rating:48Neutral
Price Target:
HK$0.25
▲(12.27% Upside)
Action:ReiteratedDate:11/25/25
The overall stock score is primarily impacted by financial performance challenges, including negative equity and profitability issues. While technical analysis shows positive momentum, the valuation remains unattractive due to a negative P/E ratio. The absence of earnings call data and corporate events means these factors do not influence the score.
Positive Factors
Strong revenue growth
A >200% year growth indicates rapidly expanding demand or successful commercial recovery. Sustained top-line expansion improves fixed-cost absorption, supports operating leverage, and creates a runway for margins and cash generation if the company can steady execution.
Negative Factors
Negative shareholders' equity and high leverage
Negative equity and heavy leverage undermine financial resilience, restrict access to new financing, and raise default or restructuring risk. This structural weakness limits strategic flexibility and increases vulnerability to adverse shocks.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong revenue growth
A >200% year growth indicates rapidly expanding demand or successful commercial recovery. Sustained top-line expansion improves fixed-cost absorption, supports operating leverage, and creates a runway for margins and cash generation if the company can steady execution.
Read all positive factors
Sinopharm Tech Holdings Limited (8156) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$183.77M
Dividend YieldN/A
Average Volume (3M)157.92K
Price to Earnings (P/E)―
Beta (1Y)0.25
Revenue Growth67.24%
EPS GrowthN/A
CountryHK
Employees30
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding633,693,050
10 Day Avg. Volume46,340
30 Day Avg. Volume157,918
Financial Highlights & Ratios
PEG Ratio1.01
Price to Book (P/B)-2.33
Price to Sales (P/S)1.40
P/FCF Ratio-11.93
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Sinopharm Tech Holdings Limited Business Overview & Revenue Model
Company Description
Sinopharm Tech Holdings Limited, an investment holding company, engages in lottery business in the People's Republic of China and Hong Kong. The company operates through Provision of Lottery-Related Services, Provision of Internet Plus Services, M...
How the Company Makes Money
null...
Sinopharm Tech Holdings Limited Financial Statement Overview
Summary
Income Statement
45
Neutral
Balance Sheet
30
Negative
Cash Flow
40
Negative
| Breakdown | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 61.25M | 41.28M | 42.84M | 40.98M | 77.81M |
| Gross Profit | 13.52M | 5.02M | 5.47M | 5.10M | 20.88M |
| EBITDA | 6.11M | 4.98M | -1.01M | -75.17M | -89.65M |
| Net Income | -867.00K | -19.70M | -10.63M | -88.00M | -106.34M |
Balance Sheet | |||||
| Total Assets | 51.74M | 44.49M | 33.48M | 76.89M | 135.90M |
| Cash, Cash Equivalents and Short-Term Investments | 6.95M | 2.64M | 1.78M | 2.99M | 7.48M |
| Total Debt | 46.73M | 73.26M | 53.00M | 45.93M | 108.03M |
| Total Liabilities | 88.43M | 250.09M | 213.24M | 250.28M | 276.46M |
| Stockholders Equity | -36.87M | -199.48M | -172.73M | -166.78M | -138.88M |
Cash Flow | |||||
| Free Cash Flow | -7.21M | -12.58M | 4.73M | -36.88M | -16.32M |
| Operating Cash Flow | -7.21M | -9.25M | 4.73M | -36.76M | -6.21M |
| Investing Cash Flow | -9.00K | -4.86M | 2.00K | -85.00K | -5.05M |
| Financing Cash Flow | 11.50M | 14.98M | -4.52M | 32.24M | 12.46M |
Sinopharm Tech Holdings Limited Technical Analysis
Negative
0.22
Price Trends
0.29
Negative
0.30
Negative
0.29
Negative
Market Momentum
-0.01
Positive
27.65
Positive
15.58
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8156, the sentiment is Negative. The current price of 0.22 is below the 20-day moving average (MA) of 0.28, below the 50-day MA of 0.29, and below the 200-day MA of 0.29, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 27.65 is Positive, neither overbought nor oversold. The STOCH value of 15.58 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:8156.
Sinopharm Tech Holdings Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | HK$35.77M | -8.62 | -7.29% | ― | -13.22% | -33.33% | |
55 Neutral | HK$111.11M | -28.56 | -2.72% | 0.57% | -25.90% | -284.85% | |
54 Neutral | HK$62.00M | 267.44 | -0.57% | ― | -8.82% | ― | |
48 Neutral | HK$39.56M | 1.14 | 418.60% | ― | 4.22% | ― | |
48 Neutral | HK$183.77M | -12.91 | -1.65% | ― | 67.24% | ― | |
43 Neutral | HK$56.23M | -21.75 | -65.20% | ― | 36.44% | 31.25% |
* Technology Sector Average
HK:8156
Sinopharm Tech Holdings Limited
0.26
0.16
155.00%
HK:8071
China Netcom Technology Holdings Limited
0.01
-0.03
-70.27%
HK:8036
eBroker Group Limited
0.04
<0.01
12.90%
HK:8100
GET Holdings Limited
0.25
0.11
78.57%
HK:8131
abc Multiactive Limited
0.07
-0.02
-23.33%
HK:8290
Ahsay Backup Software Development Company Limited
0.03
0.01
72.22%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.